<html>
<head>PUBMED IDs for GATAD2A</head>
<body bgcolor='#C5F0F2'><h1>GATAD2A</h1><a href='https://pubmed.ncbi.nlm.nih.gov/22325160/'>Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci.</a> July 14  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22325147/'>Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.</a> September 13  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23239876/'>Unique features of the anti-parallel, heterodimeric coiled-coil interaction between methyl-cytosine binding domain 2 (MBD2) homologues and GATA zinc finger domain containing 2A (GATAD2A/p66α).</a> March 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/25825869/'>The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex.</a> August 5  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27732854/'>ZMYND8 Co-localizes with NuRD on Target Genes and Regulates Poly(ADP-Ribose)-Dependent Recruitment of GATAD2A/NuRD to Sites of DNA Damage.</a> October 13  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28094816/'>Methylation specific targeting of a chromatin remodeling complex from sponges to humans.</a> January 18  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28260108/'>Knockdown of GATAD2A suppresses cell proliferation in thyroid cancer in vitro.</a> March 6  2017<br></body></html>
